Atlas Trials

Moleculin Biotech, Inc.

7 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Moleculin Biotech, Inc.

RecordFirmDate
L-Annamycin for Injection in Combination With Cytarabine Injection as Second Line Therapy for Remission Induction in Adult Subjects With Refractory/Relapsed AML (NCT06788756)Moleculin Biotech, Inc.2025-03-12
Study of Liposomal Annamycin in Combination With Cytarabine for the Treatment of Subjects With Acute Myeloid Leukemia (AML) (NCT05319587)Moleculin Biotech, Inc.2022-09-29
Study to Assess the Safety and Pharmacokinetics of WP1122 in Healthy Volunteers (NCT05195723)Moleculin Biotech, Inc.2022-05-11
Study of Liposomal Annamycin for the Treatment of Subjects with Soft-Tissue Sarcomas (STS) with Pulmonary Metastases (NCT04887298)Moleculin Biotech, Inc.2021-06-05
Study of WP1220 for the Treatment of Adult Subjects With Cutaneous T-Cell Lymphoma (CTCL) (NCT04702503)Moleculin Biotech, Inc.2019-03-08
Study of Liposomal Annamycin for the Treatment of Subjects With Acute Myeloid Leukemia (AML) (NCT03388749)Moleculin Biotech, Inc.2018-12-17
Study of Liposomal Annamycin for the Treatment of Subjects With Acute Myeloid Leukemia (AML) (NCT03315039)Moleculin Biotech, Inc.2018-03-28

Track Moleculin Biotech, Inc. automatically

Every clearance here is in the API, with alerts when new ones post.